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ABSTRACT 
Development of in vitro Chylomicron Assay Using Caco-2 Cells 
by 
Yuxi Sun 
Dietary fats are mainly transported by the intestine in lipoproteins: chylomicrons (CMs) and very 
low density lipoproteins (VLDLs). Unfortunately, studies of the intestinal absorption of dietary 
fat have been hampered by the lack of an adequate in vitro model system. As an in vitro model 
Caco-2 cells are able to secrete lipoproteins. We investigated the possible factors that may affect 
the secretion of CMs through the ultracentrifugation technique. The dose-dependent effects of 
oleic acid, mono-olein, egg lecithin, collagen matrix, and the effect of cell differentiation on CM 
secretion were then tested. We found that oleic acid, lecithin, and cell differentiation are critical 
for CM secretion by Caco-2 cells. To further confirm that our optimal condition is, in fact, 
favorable for efficient CM production, we compared it with control groups. We observed that our 
condition led to more efficient CM secretion as determined by the TGs, ApoB, and TEM 
analysis. 
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CHAPTER 1 
INTRODUCTION 
 Obesity has been in a dramatic increase in the United States. About one-third of U.S. 
adults are obese and approximately 17% of children and adolescents are obese in 2010 according 
to Centers for Disease Control and Prevention (36). Unregulated food intake is known to be one 
of the main causes of obesity. Dietary lipids, the main composition in a western diet pattern, are 
absorbed by the small intestine and packed into 2 types of lipoproteins for transportation: CM 
and VLDL. However, the difference between CM and VLDL is not clearly understood including 
their different roles in developing obesity. In our study the production of CM is optimized in 
vitro to provide a tool for lipid-related studies. 
Lipid Digestion 
Before being absorbed by the small intestine, dietary lipids are processed in sequential 
steps: emulsification, hydrolysis, and micellization. Multiple processes are used to increase the 
surface area of the lipid droplets. First, physical force tears the lipid droplet down when stomach 
chime is propelled into duodenum through a small opening of pyloric orifice. Then 
emulsification further breaks the lipids droplet through amphipathic bile in the small intestine. 
The hydrophobic portion of amphipathic bile interferes with the lipids on the surface of lipid 
droplets and weakens the stability of lipid droplets which are broken down into smaller lipid 
droplets. Two enzymes, pancreatic lipase and phospholipase A2, hydrolyze dietary lipids and 
liberate hydrolysis products from lipid droplets. Further being mixed with bile, hydrolysis 
products are packed into micelle to pass through the unstirred water layer above the brush border 
membrane and taken up by enterocytes after micelles are disintegrated (3). 
10 
The importance of bile to emulsification and micellization is indicated by the decreased 
rate of lipid absorption in humans with bile fistulas (20). Such study indicates that bile in the 
duodenum is important for lipid absorption if not absolutely necessary. However, elevated 
concentrations of bile are shown to inhibit pancreatic lipase activity (14). 
Digestion of Triglyceride 
 About 95% of dietary lipids are TGs while 5% consist of cholesterol, phospholipids, and 
other lipids. TG is digested by pancreatic lipase producing sn-2 monoglyceride (MG) and free 
fatty acids. sn-2 MG is the predominant form of TG hydrolysis products when other forms of 
MG could not be absorbed by enterocytes (32). 
Digestion of Phospholipids 
Dietary phospholipids are hydrolyzed by pancreatic phospholipase A2 into fatty acids 
and lysophospolipids in the intestinal lumen before absorbed by the enterocytes. Like TG, 
phospholipids hydrolysis products are esterified back into phospholipids and packed into 
lipoprotein as structural outer layer. Phospholipase A2 knockout mice are indistinguishable from 
wild-type controls when fed regular chow except for their resistance to diet-induced obesity (3).  
Uptake of Monoglyceride and Free Fatty Acid 
 While MG is taken up through protein-independent diffusion, uptake of fatty acids is 
likely through both protein-independent diffusion and protein-dependent transportation. The 
evidence for passive diffusion is that the uptake of fatty acid is not affected by protease treatment 
in vitro (23). Similar result were reported in adipocytes when flip-flop mechanism was found to 
transport fatty acids across the apical membrane of epithelial cells (22). The evidence for active 
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transport is that fatty acid uptake can be saturated and there are competitions for uptake between 
different fatty acids. A number of candidate proteins are proposed to function in protein-
dependent transportation. First, FAT/CD36, highly expressed in enterocytes, was reported to 
have effects in the uptake of fatty acids (7). The expression of FAT/CD36 is upregulated by 
dietary fat. However, the controversy also exists because only the secretion of lipoproteins is 
impaired in CD36-null animals but the uptake of fatty acid is not (9). The second candidate is 
FATP. FATP has 6 different proteins in which FATP4 is predominantly expressed in the 
intestine. FATP is believed to help facilitate the uptake of fatty acid by the intestine, supported 
by the fact that 40-50% of fatty acid uptake is reduced in knockdown animals (27). The third 
candidate is FABPpm that has been localized on the brush border membranes of enterocytes. The 
antibodies to FABPpm also reduce the fatty acid uptake (15). 
Assembly of Triglyceride in Enterocytes 
Through either diffusion or protein-dependent transport, TG hydrolysis products are 
absorbed by enterocytes and traverse into endoplasmic reticulum (ER) for reesterifying back into 
TG. Two binding proteins to traverse TG hydrolysis products in enterocytes are liver FABP and 
intestinal FABP(4). Inside the ER, TG is assembled in 2 pathways: MG pathway and glycerol-3-
phosphate pathway. The MG pathway covalently joins MG and fatty acyl-CoA to form 
diglyceride (DG) by MGAT (5) and further acylation of DG by DGAT leads to the production of 
TG. The MG pathway is the major pathway for TG biosynthesis, especially predominant when 
sufficient lumen MG and fatty acids are supplied in the postprandial state.  Two DGATs are 
identified and characterized: DGAT1 and DGAT2. Lipid absorption is impaired in DGAT2-
knockout animal but not DGAT1-knockout animal (35). Another pathway, glycerol-3-phosphate 
pathway, is used to assemble TG when lumen MG and fatty acid are not available in the fasting 
12 
state. The addition of 2 fatty acyl CoAs to glycerolphosphate leads the production of 
phosphatidic acid catalyzed by glycerol-phosphate acyltransferase (GPAT) and acyl-glycerol-
phosphate acyltransferase (AGPAT). Phosphatidate is then dephosphorylated by phosphatidic 
acid phohydrolase (PAP) to yield DG, and another fatty acyl CoA addition leads to TG (37) (See 
Figure 1). 
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Figure 1. Two Pathways for TG Synthesis: MG pathway and glycerol-3-phosphate pathway. In 
MG pathway, MG is acylated by MGAT and DGAT to assemble TG. In glycerol-3-phosphate 
pathway, glycerol-3-phosphate is joined by 2 FA CoA catalyzed by GPAT and AGPA and 
dephosphorylated by PAP to yield DG. Addition of FA CoA to DG yields TG (adapted from Yen 
2008) 
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Lipoprotein Production 
After being absorbed by enterocytes, lipids hydrolysis products are reesterified and 
packaged into lipoproteins to be transported in hydrophilic environment. There are some key 
proteins that are known to affect intestinal lipoprotein secretions: Apolipoprotein B-48, 
microsomal TG transfer protein (MTP), and ApoA-IV. 
Apolipoprotein B-48 
ApoB is essential for lipoprotein assembly in the small intestine and there is only one 
ApoB per lipoprotein (1). Two forms of ApoB, intestine-only ApoB-48 and ApoB-100, are 
encoded by the same gene. In order to produce ApoB-48 in the intestines, nucleotide of ApoB 
mRNA is converted from a cytidine to urideine. As a consequence, a stop codon replaces 
original glutamine, leading to only the NH2-terminal mRNA translated. Therefore, ApoB-48 lost 
the ability to bind LDL-receptor with only 48% of apoB100 left. Besides this, lipoprotein with 
ApoB-48 is also proved to be a better transporter under high concentrations of lipids (23). Fatty 
acid could dramatically increase the secretion of ApoB-48 contained lipoproteins without mRNA 
of ApoB increased (17). It is believed that ApoB-48 synthesis is consecutive and constant. In 
preprandial state, ApoB-48 without being lipidated would be degraded by the ubiquitin-
proteasome system after assembled due to lack of fatty acids and in the postprandial state 
increased fatty acids with similar ApoB amounts lead to an increase in size of lipoproteins. 
Microsomal Triglycerides Protein 
MTP is used for transportation of newly-synthesized TG to newly translated ApoB in the 
ER lumen of small intestine and liver. The initial lipidation of ApoB by MTP protects ApoB 
from proteasome degradation. The large subunit of MTP is responsible for lipid transfer subunit 
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and the small subunit of MTP is identical to protein disulfide isomerase (PDI) (18). 
Abetalipoproteinemia is caused by mutation in the large subunit of MTP that is characterized by 
an inability to secrete intestinal chylomicrons or hepatic VLDL. 
Apolipoprotein A-IV 
Apolipoprotein A-IV (Apo A-IV), expressed predominantly in the small intestine, is a 
lipid binding protein. Despite numerous functions that have been described, ApoA-IV has a 
primary role in the intestinal lipid absorption. As the most responsive to intestinal lipid flux, Apo 
A-IV is incorporated into nascent chylomicrons in the ER and is secreted on the surface of 
chylomicrons (30). 
Chylomicron vs. Very Low Density Lipoprotein 
CM and VLDL are lipoproteins secreted by enterocytes when CM has a diameter of 80 
nm or larger and VLDL is smaller than 80 nm in diameter. VLDL is predominant in the fasting 
state and more CM is secreted in the postprandial state. CM is considered as a more efficient 
lipid transporter than VLDL. In the preprandial state, only 0.7% of lymph lipoproteins were 
CMs. In the postprandial state, around 39% of lymph lipoproteins were CMs for dietary fat 
transportation (26). Pluronic 81 is capable of blocking the production of CM from Caco-2 cell 
but not the production of VLDL. This suggests that the production of CM and VLDL use 
different pathways (10).  
Chylomicron Production 
Formation of chylomicron has multiple steps. The first step, ApoB-48, synthesized in 
rough endoplasmic reticulum (RER), is chaperoned by MTP. Newly synthesized ApoB-48 is 
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either assembled with cholesterol, phospholipids, and small amounts of TG to form stable 
complex dense particles (DP) or is degraded when lipids are not available. Then in smooth 
endoplasmic reticulum (SER), MTP carries TG and cholesterol ester to enlarge the particle that 
merges with Apo A-IV (18). Then prechylomicron is formed that contains a core of neutral lipids 
surrounded by a monolayer of phospholipid with ApoB-48 and ApoA-IV. L-FABP may facilitate 
budding of the preCM transport vesicle (PCTV). The PCTV fuses to the cis-Golgi via coating 
protein II and soluble N-ethymaleimide-sensitive factor attachment protein receptor (SNARE) 
protein. After final processing in the Golgi, the mature CM is secreted via the basolateral 
membrane (2). 
Physiology of the Intestinal Mucosa 
 Epithelium cells of the small intestine secreted lipoproteins from basolateral membrane 
into lamina propria where there are both lymphatic capillaries (lacteal) and blood capillaries 
(fenestrated capillaries). The large gaps between lacteal are considered much larger than the size 
of lipoproteins so that all lipoprotein are assumed to enter the lymphatic system. That is the 
reason lipoproteins studied in vivo are collected from the lymph. However, the pore size of the 
fenestrated capillaries is about 60-80 nm in diameter. In addition to fast flow in blood capillaries, 
some VLDLs enter the blood capillaries and are taken up by the liver. 
Caco-2 Cells 
Caco-2 cells derived from a human colorectal carcinoma could differentiate into 
enterocyte-like function and morphology such as apical microvilli, associated brush border 
hydrolase, sucrose-isomaltase that is an enterocyte-specific differentiation marker and functional 
tight junction barrier that is indicated by high transepithelial electrical resistance (17). Sucrase 
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ctivity can be detected after confluence and gradually increase until 14-20 days postconfluent. 
Some chemicals like collagen matrix are known to affect the growth of Caco-2 cells (2). 
Apolipoprotein B 48 vs. Apolipoprotein B-100 from Caco-2 Cells 
Despite that Caco-2 cells are intestine-derived, it can assemble both intestinal and hepatic 
forms of ApoB. Some studies showed that more hepatic-only ApoB-100 is secreted than ApoB-
48 (24). However, the ratio of ApoB-48/ApoB-100 can be affected by growth and differentiation. 
Caco-2 cells predominantly produced ApoB-100 when cultured directly on plastic plates (24). 
But when cultured on filter or semipermeable membranes, Caco-2 cells synthesize more ApoB-
48 than ApoB-100 (13). The difference is probably due to the degree of polarization or 
maturation based on different growth supports. Besides Caco-2 cell line model, small intestinal 
explants model also produces ApoB-100, implying that mRNA editing to ApoB-48 is incomplete 
(21). 
Criticism on Caco-2 Cells 
There are also criticisms for using Caco-2 cells as an in vitro model. The primary 
criticism is their poor lipid secretion efficiency, particularly their CM secretion efficiency. Most 
studies associated with CMs had to use sensitive test methods, e.g. radiolabeled lipids. In our 
studies, we optimized the conditions for Caco-2 cells to secrete CMs so that the lipids secreted 
can be detected by colorimetric assay and the particles can be visualized by TEM.  
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CHAPTER 2 
MATERIALS AND METHODS 
Caco-2 Cells 
The human adenocarcinoma, Caco-2, cells were obtained from American Type culture 
Collection (Rockville, MD), and grown and maintained with growth media (DMEM with 15% 
FBS) in 5% CO2 at 37°C.  Cells were split at 1:6 ratio when they reached 50-70% confluent, and 
media was changed every other day. To determine optimal condition for CM secretion, cells 
were maintained in 10 cm culture dishes until they reached at least 13 days postconfluence. To 
further comfirm the optimal conditional, cells were cultured on Tranwellsand its condition was 
compared with the commonly reported condition (25). The prefiltered lipid mixture (unless 
specified, Oleic Acid: Lecithin: NaTC = 2 mM: 1.36 mM: 1.0 mM) in 10 ml growth media was 
added to the cells to induce the secretion of CMs. Cells that were grown on culture dishes were 
incubated with lipid mixture for 4 hours; washed with PBS twice, and replaced with fresh growth 
media to collect the secreted lipoproteins. Cells grown in Transwells were incubated with lipid 
mixture in apical chamber for 4 hours: the basolateral chamber was added with fresh growth 
media (no lipid mixture) to collect the secreted lipoproteins.  
Sequential NaCl Density Gradient Ultracentrifugation 
Sequential NaCl density gradient ultracentrifugation was used to isolate CMs and VLDLs 
from the basolateral media of the Caco-2 cells. Media collected from cells were mixed with NaCl 
and water to obtain the density of 1.20 g/ml. The 1.20 g/ml density mixture was then carefully 
overlaid with 500 µl of water and subjected to sequential ultracentrifugation. The top 500 µl 
(CM fraction) was isolated after 30 minute spin at 10,000 rpm (Thermo T865 rotor). The 
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remaining mixture was similarly overlaid with 500 µl of water and spun at 65,000 rpm for 24 
hours. The top 500 µl of VLDL fraction was isolated by gentle pipetting. 
Fat Red 7B 
For the purpose of visualizing the lipid layers on the ultracentrifugation samples, 
colorless media (without the pH indicator phenol red) was used to collect the secreted 
lipoproteins. The colorless lipoprotein-containing media was added with 200 µl of Fat Red 7B 
solution (2 mg/ml Fat Red 7B in 0.1M NaOH with 1 drop of Triton) and were subjected to 
sequential NaCl gradient ultracentrifugation as described above. Digital pictures were taken after 
each spin. With the exception of this experiment, no other experiments used colorless media for 
Fat Red 7B staining. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
ApoB was quantified by a sandwich ELISA method. High binding 96-well plates 
(Thermo Scientific Cat# 62409-002) were coated with monoclonal anti-ApoB antibody (Thermo 
Scientific Cat#HYB069-02-02; 100 µl in each well; 1:5,000 dilution in Voller’s buffer (2.76g 
Na2CO3, 1.916g NaHCO3, 0.2g NaN3 in 1L, pH=9.2)) followed by blocking with 5% BSA in 
PBS-0.5% Tween (PBS-T). After coating, each well was washed 3 times with PBS-T. 100 µl of 
ApoB standard (Alpha Diagnose Cat# APOB25-N-100) or samples were added into each well 
and incubated. Each well was then washed 3 times and incubated with the goat anti-ApoB 
antibody (diluted in 1:2000; Rockland Cat# 600101111). After being washed 5 times, each well 
was incubated with anti-goat horseradish peroxidase-conjugated secondary antibody (diluted 
1:2,000; Thermo Scientific Cat# 31402). Peroxidase substrate (Bio-Rad Cat# 172-1064) was 
added and the absorbance was read according to manufacturer’s suggested protocol. 
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Triglycerides Measurement 
The concentration of TGs was measured by using colorimetric assay, as described 
previously (33). 
Transmission Electron Microscopy 
Samples were negatively stained by using freshly prepared 2% phosphotungstic acid, pH 
6.0, as previously described (33). They were then examined by using Philips Technai 10 and 
representative pictures were taken. 
Optimizing Chylomicron Secretion 
Variables including differentiation stage, lipid mixture composition, lipid mixture 
incubation time, lipoprotein collection time, and collagen matrix were tested. 
Differentiation Stage 
Caco-2 cells that have reached 4, 13, 17, and 23 days postconfluent were used to study 
the effect of differentiation stage on lipoprotein secretion. They were incubated with prefiltered 
lipid mixture (oleic acid: egg-lecithin: NaTC= 4 mM: 1 mM: 0.68 mM: 1.0 mM) in growth 
medium for 4 hours. The lipid mixture was then removed; the cells were washed twice with PBS, 
and incubated with fresh growth media for 2 hours. The collected media were subjected to 
sequential NaCl gradient ultracentrifugation for the isolation of the lipoprotein fractions followed 
by TG analysis, as described above. 
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Lipid Mixture Composition 
The dose-dependent effects of the hydrolysis products of dietary lipids on lipoprotein 
secretion were studied. The hydrolysis products that we tested included oleic acids, mono-olein, 
and egg-lecithin. Caco-2 cells were used when they were between 13 days and 15 days 
postconfluent. Cells were incubated with lipid mixture (oleic acid: mono-olein: egg-lecithin: 
NaTC= 2 mM: 1.32 mM: 1.0 mM) in 10 ml of growth media for 4 hours, washed twice, followed 
by incubation with fresh growth media for 2 hours. Similarly, the collected media were subjected 
to sequential NaCl gradient ultracentrifugation for the isolation of the lipoprotein fractions 
followed by TG analysis. 
For the oleic acid experiment, 0, 2, 4, and 6 mM of oleic acids in 1mM mono-olein, 
0.68mM lecithin, and 1mM NaTC in growth media were used. For mono-olein experiment, 0, 1, 
2, or 4 mM of mono-olein in 2 mM oleic acids, 0.68 mM lecithin, and 1.0 mM NaTC in growth 
media were used. For the lecithin experiment, 0, 0.68, 1.36, or 2.72 mM of lecithin in 2 mM 
oleic acids and 1.0 mM NaTC in growth media were used. 
Thin Layer Chromatography Analysis 
The egg-lecithin was analyzed by TLC (33) to confirm the presence of 
lysophosphatidylcholine (lysoPC). Half milligram of lysoPC and 2 mg of egg-lecithin in 
chloroform were separated on silica gel 60 plates using chloroform : methanol : acetic acid : 
water (50/37.5/3.5/2) (v/v) as the solvent system.  The plate was stained with choline staining (2 
g potassium iodide, 4 ml acetic acid, 0.34 g bismuth subnitrate in 100 ml total volume) followed 
by 20% sulfuric acid staining with 225°F heating until the color developed. 
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Incubation Time and Collection Time 
After Caco-2 cells have reached 13 days postconfluent, lipid mixture (2 mM oleic acids, 
1.36 mM lecithin and 1.0 mM NaTC) in 10 ml growth media were added to the cells for either 2 
or 4 hours. Cells were washed twice with PBS, and incubated with growth media for either 2 or 4 
hours. The collected media were subjected to sequential NaCl gradient ultracentrifugation for the 
isolation of the lipoprotein fractions followed by TG analysis. 
Collagen Matrix 
Tissue culture dishes (10 cm) were precoated with 0, 50, 100, or 500µg collagen per plate 
according to manufacturer’s suggested protocol (MP Biomedical Cat# 160084). After the cells 
have reached 13 days postconfluent, lipid mixture (2 mM Oleic Acid, 1.36 mM lecithin, and 1.0 
mM NaTC) in 10 ml growth media were added to the cells and incubated for 4 hours. The cell 
were washed twice and incubated with fresh growth media for 2 hours. The collected media were 
subjected to sequential NaCl gradient ultracentrifugation for the isolation of the lipoprotein 
fractions followed by TG analysis.  
Comparing the Optimal Condition with the Control Groups 
Cells were cultured Transwell, as described previously (34). For the optimal condition 
(O), the preferred lipid mixture (2 mM oleic acids, 1.36 mM lecithin and 1.0 mM NaTC) in 10 
ml growth media were added to the apical chamber and growth media without lipid were added 
to the basolateral chamber, followed by 4 hours incubation. For the condition with low lipid 
(LL), lipid mixture containing 1.6 mM oleic acid and 0.5 mM NaTC in 10 ml growth media were 
added to the apical chamber and growth media without lipid were added to the basolateral 
chamber, followed by 14 hours incubation. For the condition with no lipid (NL), growth media 
23 
without lipid were added to both the apical and basolateral chambers and incubated for 4 hours. 
The collected basolateral media were mixed with protease inhibitor and subjected to sequential 
NaCl gradient ultracentrifugation for the isolation of the lipoprotein fractions followed by TG, 
ELISA, TEM, and Western blot analysis. One-step NaCl density gradient ultracentrifugation was 
used instead. In one-step NaCl gradient ultracentrifugation, CMs and VLDLs were isolated as 
one single fraction by skipping the 30 minutes spin at 10,000 rpm. 
Lipoprotein Particle Size Analysis 
Lipoprotein samples from O, LL, and NL that were isolated by one-step NaCl density 
gradient ultracentrifugation were negatively stained with 2% phosphotungstic acid (pH= 6.0), as 
previously described (33). The size of the lipoprotein particles was measured through 
representative TEM pictures. For each group, at least 800 particles were counted per sample.   
SDS Polyacrylamide Gel Electrophoresis and Immunoblotting 
The lipoprotein fraction (10 µl) isolated by one-step NaCl density gradient 
ultracentrifugation method was run on the 4-20% polyacrylamide gel (Bio-Rad Cat# 456-1096) 
using the suggested manufacturer’s protocol. The proteins were then transferred to nitrocellulose 
membrane and blocked with 5% skim milk in TBS-T for 30 minutes. The membrane was 
incubated with monoclonal antiApoB antibodies (Thermo Scientific Cat# HYB069-02-02; 
1:5,000 dilution in blocking buffer). After 2 washes with TBS-T, the membrane was incubated 
with goat antimouse antibodies (Thermo Scientific Cat#LK152970; 1:2000 dilution in blocking 
buffer). After 5 washes, the signals were detected by using the HRP substrate kit (Thermo 
Scientific Cat# NG173486). 
 
24 
High-Performance Liquid Chromatography (HPLC) 
 100 µl of the lipoprotein fraction isolated by 1-step NaCl density gradient 
ultracentrifugation injected into the 100 µl sample loop of Bio-Rad Duoflow system and 
separated by gel filtration column (Shodex Cat# SB-804HQ). About 180 of 1 ml fractions were 
collected for analysis (buffer: 0.05 M NaCl).   
Statistical Analysis 
The data shown are mean values ± standard errors (SE). To determine the statistical 
significance of 3 groups or more, 1-way ANOVA was used. t-test was used for comparison 
between 2 groups. Statistical analyses were performed in Excel (Microsoft, Seattle, WA), and 
were considered significant if P < 0.05.  n>2 for all experiments. 
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CHAPTER 3 
RESULTS 
Fat Red 7B Staining 
As shown in Figure 2, the staining spread evenly in the unfractionated lipoprotein layer 
before the ultracentrifugation. After the first spin (Figure 2A) the stain was concentrated in the 
top ~ 1 ml layer, though the bottom layer was lightly stained as well. After the second spin 
(Figure 2B) the stain appeared strongly in the top ~ 1 ml layer and the bottom layer with the 
middle layer minimally stained.  
A)                                B) 
 
Figure 2. Fat Red 7B Staining 
The heavily stained CMs (A) floated to the top ~ 1ml layer. Subsequently, the top 1 ml of 
the chylomicron fraction was replaced with 1 ml of water and spun for 24 hours at 300,000 g. 
The heavily stained VLDLs (B) were visible in the top ~ 1 ml layer. 
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Analysis on Sequential NaCl Density Gradient Ultracentrifugation 
Data in Table 1 showed the difference between CM and VLDL on TG and ApoB. The 
concentrations of ApoB from the top layer of the first and second spins were, 425.3 ng/ml and 
1612.18 ng/ml, respectively (p= 0.005). The concentration of TGs from the top layer of the first 
and second spins were 11.27 mg/dl and 12.27 mg/dl, respectively (p= 0.69). 
Lipoprotein Fractions Isolated by Sequential NaCl Gradient Ultracentrifugation 
 ApoB (ng/ml) TG (mg/dl) 
CM 425.3 ± 139.2 11.27 ± 0.945 
VLDL 1612.18 ± 160.56 12.27 ± 2.15 
Table 1. Lipoprotein Fractions Isolated by Sequential NaCl Gradient Ultracentrifugation  
As shown in Figure 3, both CM and VLDL fractions were analyzed for their 
Apolipoprotein B (A) (p= 0.005), TG (B) (p=0.69) and particle size using the transmission 
electron microcopy with negative staining method. Notice that the particles in the CM fraction 
(C) were larger than those in the VLDL fraction (D). 
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A)                                                                      B)   
  
C) 
 
Figure 3 (continued on the next page) 
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D) 
 
Figure 3. Lipoprotein Fractions Isolated by Sequential Gradient Ultracentrifugation 
Optimizing Chylomicron Secretion: Differentiation Stage 
 Data in Table 2 show the effect of cell differentiation on CM and VLDL secretion. 
The Effect of Cell Differentiation on Lipoprotein Secretion 
Days postconfluent (days) CM (mg/dl) VLDL (mg/dl) 
4 5.99 ± 0.305 9.29 ± 1.39 
13 8.19 ± 1.05 13.87 ± 2.46 
17 11.81 ± 1.86 11.95 ± 1.80 
23 7.09 ± 1.16 11.32 ± 1.87 
Table 2. The Effect of Cell Differentiation on Lipoprotein Secretion 
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To determine the efficiency of lipoprotein secretion, TG concentrations from both the 
CM and VLDL layers were measured. As shown in Figure 4A, Caco-2 cells that have reached 13 
and 17 days postconfluent were more efficient in CM secretion than those of 4 and 23 days 
postconfluent (p= 0.0094) but there was no significant difference between the 13 and 17 days 
postconfluent. Figure 4B shows that the efficiency of VLDL secretion was not significantly 
affected by cellular differentiation stage (p=0.449). 
A)                                                                       B)     
   
Figure 4. The Effect of Cell Differentiation on Lipoprotein Secretion 
Caco-2 cells were grown on 10 cm plate until they reached 4, 13, 17, or 23 days 
postconfluent. The cells were then incubated with 4mM oleic acid, 1mM mono-olein, 0.68mM 
egg lecithin and 1mM NaTC in 10 ml growth media.  After 4 hours of incubation, the cells were 
washed twice with PBS and replaced with fresh growth media. After 2 hours, the media was 
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collected. The collected media was subjected to sequential gradient ultracentrifugation. The 
triglyceride concentrations in the CM (A) ( p= 0.0094) and VLDL (B) fractions were measured 
using a colorimetric assay. n =>3. 
Optimizing Chylomicron Secretion: Oleic Acids 
As shown in Table 3, oleic acids significantly affected the efficiency of chylomicron 
secretion (p= 0.0017) but not VLDL secretion (p= 0.679). 2 mM oleic acids resulted in the most 
efficient CM secretion. Our preliminary data showed that 0.5 and 1 mM oleic acids resulted in 
lower efficiency of chylomicron secretion than 2 mM oleic acids (data not shown). 
Dose-dependent Effects of Oleic Acids on Lipoprotein Secretion 
OA Concentration (mM) CM (mg/dl) VLDL (mg/dl) 
0 6.24 ± 0.37 8.992 ± 1.01 
2 12.74 ± 0.82 12.04 ±1.23 
4 10.08 ± 0.89 12.81 ± 1.44 
6 8.08 ± 0.61 12.63 ± 2.79 
Table 3: Dose-dependent Effects of Oleic Acids on Lipoprotein Secretion 
 These data showed the cell differentiation affected the CM secretion but not VLDL 
fraction. (See Figure 5) 
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A)                                                                        B) 
Figure 5. The Effect of Cell Differentiation on Lipoprotein Secretion 
Caco-2 cells were grown on 10 cm plastic plate until they reached 13 day postconfluent. 
The cells were then incubated with varying amount of lipid. Cells were incubated with 0, 2, 4, or 
6 mM of OA in 0.68 mM lecithin, 1 mM MG, and 1 mM NaTC. After 4 hours of incubation, the 
cells were washed twice with PBS and replaced with fresh growth media. After 2 hours, the 
media was collected. The collected media was subjected to sequential NaCl gradient 
ultracentrifugation. The triglyceride concentrations in the CM (A) (p= 0.0017) and VLDL (B) 
(p=0.679) fractions were measured using a colorimetric assay. n=>3 
Optimizing Chylomicron Secretion: Mono-olein 
As shown in Table 4, different concentrations of MG did not significantly affect the 
production of CM (p=0.35) or VLDL (p=0.74).   
 
* 
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Dose-dependent Effects of Mono-olein on Lipoprotein Secretion 
MG concentration (mM)  CM (mg/dl) VLDL (mg/dl) 
0 8.906 ± 0.73 9.7 ± 0.87 
1 10.09 ± 1.76 9.76 ± 0.90 
2 7.79 ± 0.68 8.96 ± 1.07 
4 5.75 ± 0.72 7.72 ± 1.30 
Table 4: Dose-dependent Effects of Mono-olein on Lipoprotein Secretion 
As shown in Figure 6, mono-olein did not significantly affect the efficiency of either 
chylomicron secretion (p= 0.358) or VLDL secretion (p=0.749), as shown in Figure 5A and 5B, 
respectively. 
A)                                                                      B)                        
 
Figure 6. Dose-dependent Effects of Mono-olein on Lipoprotein Secretion 
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Caco-2 cells were grown on 10 cm plate until they reached 13 day postconfluent. The 
cells were then incubated with varying amount of lipid. Cells were treated with 0, 1, 2, or 4 mM 
MG in 2 mM oleic acid, 0.68 mM egg lecithin and 1mM NaTC. After 4 hours of incubation, the 
cells were washed twice with PBS and replaced with fresh growth media. After 2 hours, the 
media was collected. The collected media was subjected to sequential NaCl gradient 
ultracentrifugation and the TG concentrations in their CM (A) (p= 0.358) and VLDL (B) (p= 
0.749) fractions were measured. 
Optimizing Chylomicron Secretion: Egg Lecithin 
As shown in Table 5, egg lecithin did significantly affect the CM production (p=0.022) 
but not the VLDL production (p=0.053) from Caco-2 cells. Concentrated egg lecithin induced 
Caco-2 cells to secrete significantly more CM.  
Dose-dependent Effects of Egg Lecithin on Lipoprotein Secretion 
Lecithin Concentration (mM) CM (mg/dl) VLDL (mg/dl) 
0 5.42 ± 0.49 7.2 ± 1.17 
0.68 5.77 ± 0.53 9.59 ± 1.61 
1.36 11.41 ± 1.69 13.52 ± 2.42 
2.72 12.48 ± 1.99 15.68 ± 1.91 
Table 5: Dose-dependent Effects of Egg Lecithin on Lipoprotein Secretion 
Figure 7A shows that 1.36 mM and 2.72 mM lecithin led to more efficient CM secretion 
(p=0.022). However, there was no significant difference between the 1.36 mM and the 2.72 mM 
lecithin groups. As shown in Figure 7B, lecithin did not significantly increase the efficiency of 
VLDL secretion, though the trend was clearly present (p= 0.053). 
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A)                                                                         B) 
 
Figure 7. Dose-dependent Effects of Egg Lecithin on Lipoprotein Secretion 
Caco-2 cells were grown on 10 cm plates until they reached 13 day postconfluent. The 
cells were then incubated with varying amounts of lipid. Cells were incubated with 0, 0.68, 1.36, 
or 2.72 mM egg lecithin in 2 mM OA and 1mM NaTC, After 4 hours of incubation, the cells 
were washed twice with PBS and replaced with fresh growth media. After 2 hours, the media 
was collected. The collected media was subjected to sequential NaCl gradient ultracentrifugation 
and the TG concentrations in their CM (A) (p= 0.022) and VLDL (B) (p= 0.053) fractions were 
measured. 
TLC Analysis of Egg Lecithin 
To detect the presence of lysoPC in lecithin, we performed thin layer chromatography 
followed by choline staining as shown in Figure 8. 
* * 
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 Figure 8. TLC Analysis of Egg Lecithin 
Determining the presence of lysoPC in egg-lecithin by TLC. 0.5 mg of lysoPC (left) and 
2 mg egg-lecithin (right) in chloroform were separated on silica gel 60 plates using chloroform: 
methanol: acetic acid: water (50/37.5/3.5/2) (v/v) as the solvent system.  The plate was stained 
by Choline staining (2g potassium iodide, 4 ml acetic acid, 0.34 g bismuth subnitrate in 100 ml 
total volume) followed by 20% sulfuric acid staining with 225°F heating until the color 
developed.   
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Optimizing Chylomicron Secretion: Incubation and Collection Time 
As shown in Table 6, timing did significantly affect the VLDL (p= 0.031) production but 
not the CM (p= 0.068) production  from Caco-2 cells.  
Timing Effects on Lipoprotein Secretion 
Incubation + Collection Time 
(hours) 
CM (mg/dl) VLDL (mg/dl) 
2+2 5.37 ± 0.67 6.31 ± 1.71 
2+4 9.5 ± 1.91 11.48 ± 0.50 
4+2 12.8 ± 1.22 14.53 ± 0.33 
4+4 8.68 ± 1.59 12.89 ± 2.33 
Table 6: Timing Effects on Lipoprotein Secretion 
As shown in Figure 9A and 9B, incubation and collection time did not seem to 
significantly affect the efficiency of CM (p= 0.068), but affected VLDL (p= 0.031) secretion 
significantly. Note that this time frame was chosen because lipoprotein secretion by the 
enterocytes was more pronounced during this time in both mice (33)and rats (35). 
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A)                                                                        B)  
 
Figure 9. Timing Effects on Lipoprotein Secretion 
Caco-2 cells were grown on 10 cm plate until they reached 13 days postconfluent. The 
cells were then incubated with 4 different incubation and collection combinations were tested. 
Cells that were at least 13 days postconfluent were incubated with lipid mixture (2mM oleic acid, 
1.36 egg lecithin and 1mM NaTC) for relative incubation time. Relative collection time was used 
to collect lipoproteins. Sequential NaCl gradient ultracentrifugation was conducted to collect 
chylomicron and VLDL layer. Triglyceride concentrations were measured. Figure 8A was the 
triglycerides concentration in chylomicron layer (p=0.068) and Figure 8B was determined the 
triglycerides in VLDL layer (p=0.031).  n =>3 
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Optimizing Chylomicron Secretion: Collagen Matrix 
As shown Table 7, collagen did not significantly affect the production of CM (p= 0.643)  
or VLDL (p= 0.740) production from Caco-2 cells.   
Dose-dependent Effects of Collagen Matrix on Lipoprotein Secretion 
Collagen per plate (µg) CM (mg/dl) VLDL (mg/dl) 
0 8.933 ± 1.08 17.31 ± 1.08 
50 9.47 ± 0.46 18.17 ± 2.65 
100 10.56 ± 1.47 16.27 ± 1.48 
500 8.58 ± 0.83 15.70 ± 1.16 
Table 7: Dose-dependent Effects of Collagen Matrix on Lipoprotein Secretion 
As shown in Figure 10, precoating the culture dishes with collagen did not seem to affect 
the efficiency of CM (p= 0.643) (Figure 10A) or VLDL (p= 0.740) (Figure 10B) secretions. 
However, the rate of proliferation of Caco-2 cells grown on collagen matrix was noticeably 
higher relative to the control. 
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A)                                                                            B) 
 
Figure 10. Dose-dependent Effects of Collagen Matrix on Lipoprotein Secretion 
Different amounts of collagen (0, 50, 100, 500 µl) were precoated the 10 cm culture dish 
before cells were growing on. When cells reached 13 days postconfluent, lipid mixture (2mM 
oleic acid, 1.36mM egg lecithin and 1.0mM NaTC) in 10 ml growth media was added to cells 
and incubated for 4 hours. After 2 washes with PBS, new growth media was added to collect 
lipoproteins for 2 hours. Collected media was through sequential NaCl gradient 
ultracentrifugation to isolate chylomicron and VLDL fractions followed by TG analysis. 
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Comparison of the Optimal Condition and the Control Groups 
As shown in Table 8, both ApoB and TG analysis were used on NL, LL, and O groups. 
TG concentrations from LL and O groups increased significantly compared with NL group (p= 
0.0019). ApoB concentrations from LL and O groups also increased significantly compared with 
NL group (p= 0.004).  
ApoB and TG Concentrations from CM Fractions of NL, LL, and O Groups 
 ApoB concentration (ng/ml) TG concentration (mg/dl) 
NL 0.62 ± 0.51 0 ± 0 
LL 6.77 ± 0.32 6510 ± 784.17 
O 8.35 ± 0.09 2833 ± 493.11 
Table 8. ApoB and TG Concentrations from CM Fractions of NL, LL, and O Groups  
As shown in Figure 11A, CM fractions were collected for NL, LL, and O groups as 
described in the methods. ApoB measurements (11A) and TG measurements (11B) were tested 
on each CM fractions from all groups. 
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A)                                                                   B)  
 
Figure 11. ApoB and TG concentrations from CM fractions of NL, LL, and O Groups 
As shown in Table 9, both ApoB and TG analysis were used on VLDL fractions from NL, 
LL, and O groups. TG concentrations from LL and O groups increased significantly compared 
with NL group (p= 0.0014). ApoB concentrations from LL group also increased significantly 
compared with NL and O groups (p= 0.0007).  
 ApoB and TG Concentrations from VLDL Fractions of NL, LL, and O Groups 
 ApoB concentration (ng/ml) TG concentration (mg/dl) 
NL 1.70 ± 0.17 3666 ± 578.29 
LL 10.16 ± 2.16 9590 ± 1161.92 
O 9.85 ± 0.77 4282 ± 596.38 
Table 9. ApoB and TG Concentrations from VLDL Fractions of NL, LL, and O Groups 
* * 
* 
* 
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 As shown in Figure 12, VLDL fractions were collected for NL, LL, and O groups as 
described in the methods. ApoB measurements (12A) and TG measurements (12B) were tested 
on each CM fractions from 3 groups. N>= 3 
A)                                                                        B) 
 
Figure 12. ApoB and TG Concentrations from VLDL Fractions of NL, LL, and O Groups 
TEM and Western Blot Analysis on NL, LL, and O Groups 
To further confirm the difference between NL, LL, and O groups, TEM and western blot 
analysis were performed. The lipoprotein of NL (Figure 13A) only consists of VLDLs, while 
TEM from NL groups (Figure 13B) showed more CM and TEM from O group (Figure 13C) 
showed more percentage of CM. TEM and histogram based on TEM was used to compare the 
size distribution and CM percentage. These were also confirmed by histogram (Figure 13D) and 
CM percent analysis (Figure 13F). 
 
* 
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A) 
 
B) 
 
 
Figure 13 (continued on the next page) 
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C)  
 
D) 
 
 
Figure 13 (continued on the next page) 
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E) 
 
 
F) 
 
Figure 13. TEM and Western Blot Analysis on NL, LL, and O groups 
Caco-2 cells were grown in Transwell until they reached 13 days postconfluence. For NL 
group, 13 days postconfluent cells were incubated with growth media without lipid in both the 
apical and basolateral chambers for 4 hours. For LL group,  lipid mixture (1.6 mM oleic acids 
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and 0.5 mM NaTC) in 10 ml growth media was incubated in the apical chamber and growth 
media without lipid was incubated in the basolateral chamber for 14 hours. For O group, lipid 
mixture (2 mM oleic acids, 1.36 mM lecithin and 1.0 mM NaTC) in 10 ml growth media was 
incubated in the apical chamber and growth media without lipid was incubated in the basolateral 
chamber for 4 hours. Basolateral media collected from NL (Figure 13A), LL (Figure 13B) and O 
groups (Figure 13C) was subjected to 1-step NaCl gradient ultracentrifugation and analyzed by  
TEM. In addition, the Apo B in the collected media was also analyzed by Western Blot (Figure 
13F). The lipoprotein size distribution study (Figure 13D) and CM percentage (Figure 13E) was 
based on TEM of 3 groups.  
High Performance Lipid Chromatography 
One ml fraction of HPLC samples were collected after sample running through the 
column. Detectable ApoB samples were collected and dialyzed for biochemical analysis like TG 
assay and ELISA. Although TG and ELISA could detect the lipoproteins from our sample after 
dialysis, not intact particles were observed in TEM analysis. The particle may not be intact after 
exposure in room temperature for about a week.  
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CHAPTER 4 
DISCUSSION 
Because of the low CM secretion efficiency by Caco-2 cells, sequential gradient 
ultracentrifugation has been used for CM collection (19, 25, 28). In our study modified 
sequential NaCl density gradient ultracentrifugation was used in conjunction with Fat Red 7B 
staining, ApoB and TG measurements and TEM analysis to isolate and analyze CM. Fat Red 7B, 
known to stain TG, is used to label CM and VLDL to determine their movements during the 2 
step NaCl density gradient ultracentrifugation. After the first step of low speed 
ultracentrifugation, CM was concentrated on the top ~ 1 ml while VLDLs spread evenly below 
the top fraction. CMs, less dense than VLDL, float to the top faster than VLDL under the same 
condition. Low speed ultracentrifugation could float CMs to the top layer without floating 
VLDLs up. The second ultracentrifugation step is to float VLDLs to the top through high speed 
ultracentrifugation (Figure 1). After the second ultracentrifugation, both top VLDL layer and 
bottom layer (presumed LDL) were concentrated with heavily stained particles. Through TG and 
ApoB measurements, we found that CM and VLDL fractions contained similar concentrations of 
TG while CM fraction contained significantly less lipoproteins. TG and ApoB measurements 
imply the overall lipoprotein-carrying lipids and the amount of lipoproteins, respectively. The 
average size of particle, suggested by the average lipids of each particle, can be predicted by the 
relative amount of TG to ApoB concentrations. Then the fact that less particles in CM fraction 
carries similar amount of TG suggests the averagely larger lipoproteins in CM fraction than 
particles in VLDL fraction. This result was further confirmed by TEM analysis (Figure 2). From 
TEM, we also learned that no CM is found in VLDL fraction which means our sequential NaCl 
density gradient ultracentrifugation collects all CMs in CM fraction.  
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Caco-2 cells were examined extensively in lipid studies because differentiated Caco-2 
cells displayed enterocyte-like characteristics, including secreting enterocyte-like lipoproteins. 
Differentiation was critical for Caco-2 cells to display like enterocytes. In early differentiation 
stage, Caco-2 cells gradually secreted more VLDLs before secreting CMs (Figure 3). Even 
nondifferentiated Caco-2 cells could secrete VLDLs when transfecting with human ApoB cDNA 
(27), only well-differentiated cells could secrete CM efficiently. There were 3 stages of 
differentiation in Caco-2 cells: homogeneously undifferentiated, heterogeneously differentiated, 
and homogeneously polarized differentiated cells. Studies showed that enterocyte-specific 
proteins are fully expressed in the heterogeneously differentiated stage in which we also found 
the optimal ability to secrete CM (Figure 3A). Caco-2 cells proliferated and differentiated upon 
confluence under standard culture conditions. However, other factors, like collagen and plates 
material, could affect the growth and differentiation of Caco-2 cells too. Collagen, the main 
protein fiber of connective tissue, has been shown to accelerate the proliferation of Caco-2 cells 
(2). However, collagen was not found to have significant effect on either CM or VLDL secretion 
because the cells for experiment were already well-differentiated (Figure 9). Caco-2 cells were 
also found to secrete predominantly ApoB-100 if cultured directly on plastic plates. If cultured 
on semipermeable membrane or filter, Caco-2 cells expressed more ApoB-48 than ApoB-100 
(Figure 11F).  
Mimicking the conditions of enterocytes, lipid mixture was incubated with cells to induce 
the production of CM. The lipid hydrolysis product (fatty acid, MG, and lysophospholipid) were 
reported to induce lipoprotein secretion both from enterocytes and Caco-2 cells. In our study 
oleic acid was used as the most efficient fatty acid for inducing Caco-2 cells to secrete 
lipoproteins (8, 11). We found that 2 mM oleic acid has optimal effects on inducing CM 
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production (Figure 4A). More oleic acid would be toxic to the cells because the hydrophobicity 
could disrupt the cells membranes, while less oleic acid may not supply sufficient lipids for CMs 
secretion.  
Another lipid hydrolysis product, MG, was reported to promote lipoprotein secretion 
from enterocytes and could be taken up by Caco-2 cells (16). The dose-dependent effect of 
mono-olein on CM secretion was tested while no significant effect of mono-olein on lipoprotein 
secretion was found (Figure 5). The reason could be because Caco-2 cells did not actively use 
MG pathway for TG assembles but glycerol-3-phosphate pathway (19). 
The effects of lysophospholipid effects on CM secretion are also tested by testing egg 
lecithin for the cost concerns. Through TLC analysis we found the trace of 
lysophosphatidylcholine (Figure 7), which was reported to promote lipoprotein secretion in 
Caco-2 cells (12, 31).  Significant effects on promoting CM secretion were found. However, the 
possibility of other components in egg lecithin promoting CM secretion can not be ruled out. 
Especially phosphatidylcholine, predominant in egg lecithin, is believed to promote lipoprotein 
secretion from Caco-2 cells also (31).  
Two and 4 hours of incubation or collection time were tested because physiological 
lipoprotein secretion was more pronounced during this time in both mice (33) and rats (35). 
However, the time variables only made a difference in VLDL secretion (Figure 8). Longer 
collection time allows cells to secrete more VLDL but not CM. In addition, the longer the 
incubation and collection time, the more the serum will be consumed. 
To determine if our optimal conditions were in fact capable of producing CMs efficiently, 
we compared it with 2 other groups: less lipid group and no lipid group. Less lipid group used 
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modified previously studied conditions that were reported to have CM secretion (29)and no lipid 
group used the same optimal condition except without lipid mixture incubation. Previously 
studied condition used low lipid in the apical chamber than our optimal condition as well as 
extreme low serum basolateral media to collect lipoproteins overnight. In less lipid group we 
changed original extreme low serum basolateral media to normal serum basolateral media. 
Because when extreme low serum was used in the basolateral media, the TG and ApoB 
concentrations were too low to be detected in both the CM and VLDL fractions. TEM analysis 
also confirmed very few of small lipoproteins secreted (data not shown). If Caco-2 cells were 
incubated with low serum basolateral media for 12 hours like previously reported, cells die and 
detach from the plates. This suggests that Caco-2 cells need serum in the basolateral chamber to 
stay healthy and secrete enormous and large lipoproteins. Therefore, we used 15% FBS in 
DMEM basolateral media for less lipid group instead of 0.1% FBS in DMEM that was used in 
previous study (28.) 
TG, ApoB, and TEM analysis were used to analyze CM and VLDL fractions from 3 
groups: Optimal group (our optimal condition), less lipid group (modified previously reported 
condition), and no lipid group (no lipid mixture added into cells). ApoB concentrations 
represents the lipoprotein amounts while TG concentration represents overall lipids carried by 
lipoproteins. Relative amount of TG to ApoB concentration is used to predict the average size of 
lipoproteins between groups that would be confirmed by TEM analysis.  
From CM fraction analysis of 3 groups we found that: no lipid group secretes few CMs 
suggested by nondetectable ApoB or TG concentrations; Less lipid group secretes the most 
numerous CM suggested by the highest ApoB concentrations and high TG concentrations; Our 
optimal group secretes the average largest CM suggested by high ApoB concentrations and high 
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TG concentrations. All these results are confirmed and supported by our TEM analysis.  Similar 
results were observed in VLDL fraction analysis: no lipid group secretes few VLDLs; less lipid 
group secretes most numerous VLDLs; optimal group secretes largest VLDLs.  
In previous studies ApoB concentrations did not have sufficient amounts for western blot 
without sensitive methods e.g. radiolabeled lipids (6, 17, 19, 25). Inefficient ultracentrifugation 
method and poor lipid exportation efficiency probably are the 2 main reasons. With sensitive 
detective methods, more ApoB-100 was reported to be secreted by Caco-2 cells (24). However, 
through our gradient ultracentrifugation, ApoB from our optimal condition group, less lipid 
condition group and no lipid condition group were all detected by direct western blot. And more 
ApoB-48 was detected than ApoB-100 in all 3 groups. This result supports that more ApoB-48 is 
secreted when culturing the cells on semipermeable membranes. However, from our condition, 
higher ratio of ApoB-48 to ApoB-100 was obtained.  
In our study we have improved the CM secretion efficiency so that lipoproteins could be 
detected by biochemical assay and western blot. The presence of CM secretion was analyzed by 
western blot and confirmed by TEM. And also we improved the percentage of in vitro CM 
secretion efficiency. Overall, 21% of CM secretion efficiency was obtained in vitro from our 
optimal condition, which is close to 39% in vivo efficiency (26). One possible reason for low 
efficiency in vitro was that not all VLDLs were collected in vivo. In the previous in vivo studies, 
all lipoproteins were assumed to enter lacteal because of the larger gaps between their endothelia 
cells. However, fenestrated capillaries, thought to have smaller gaps between their endothelia 
cells, had pores that are about 60-80 nm in diameter. VLDL, which was smaller than the pores, 
was able to enter the blood capillary. In the animal model lipoproteins were collected from the 
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lymph. Therefore, some of these VLDLs were not collected, skewing the data toward larger 
lipoproteins.   
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